Plan du site
[pagelist exclude= »349,367″]
Nouvelles
Early trial results support ongoing TherVacB hepatitis B patient study
New early clinical trial results support the ongoing TherVacB patient study for chronic hepatitis B.
TherVacB & D-Solve Contribute to World Hepatitis Day 2025 with Ongoing Awareness Campaign “Insights on HDV and HBV”
Stay informed, stay protected with our campaign “Insights on HDV and HBV” – everything you need to know about hepatitis D and B.
It’s time for action, it’s World Hepatitis Day 2024!
Every year, 1.3 million people lose their lives to hepatitis. New data from the World Health Organization shows the number of deaths is rising. The TherVacB team is not waiting for change. Together with researchers from the D-Solve consortium and supporting partners,...